Insulet Corporation (BMV:PODD)

Market Cap	441.51B
Revenue (ttm)	44.94B
Net Income (ttm)	8.22B
Shares Out	n/a
EPS (ttm)	113.41
PE Ratio	53.71
Forward PE	70.72
Dividend	n/a
Ex-Dividend Date	n/a

Volume	145
Average Volume	234
Open	6,170.25
Previous Close	5,118.00
Day's Range	6,170.25 - 6,170.25
52-Week Range	3,587.00 - 6,170.25
Beta	n/a
RSI	63.13
Earnings Date	Aug 7, 2025

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is cont...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 3,900
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PODD

Financial Performance

In 2024, Insulet's revenue was $2.07 billion, an increase of 22.07% compared to the previous year's $1.70 billion. Earnings were $418.30 million, an increase of 102.76%.

Financial numbers in USD